Nektar Therapeutics to Participate in Fireside Chat at the Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Summary

Nektar Therapeutics (Nasdaq: NKTR) will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021, at 2:10 p.m. ET. This event allows investors to gain insights into Nektar's strategic direction and pipeline developments. The presentation can be accessed via a webcast on Nektar's Investor Events page and will remain available for replay until July 9, 2021. Nektar is a biopharmaceutical company focused on oncology, immunology, and virology, headquartered in San Francisco.

SAN FRANCISCO, June 7, 2021 /PRNewswire/ -- Nektar Therapeutics' (Nasdaq: NKTR) senior management is scheduled to participate in a virtual fireside chat at the upcoming Goldman Sachs 42^nd Annual Global Healthcare Conference on Tuesday, June 8, 2021 at 2:10 p.m. Eastern Time.

The presentation will be accessible via a webcast through a link posted on the Investor Events section of the Nektar website: http://ir.nektar.com/events-and-presentations/events. This Webcast will be available for replay until July 9, 2021.

About Nektar
Nektar Therapeutics is a biopharmaceutical company with a robust, wholly owned R&D pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. Nektar is headquartered in San Francisco, California, with additional operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

Contact:
For Investors:
Vivian Wu of Nektar Therapeutics
628-895-0661

View original content to download multimedia:http://www.prnewswire.com/news-releases/nektar-therapeutics-to-participate-in-fireside-chat-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301306531.html

SOURCE Nektar Therapeutics

FAQ

When is Nektar Therapeutics' virtual fireside chat at the Goldman Sachs conference?

Nektar Therapeutics' virtual fireside chat is scheduled for June 8, 2021, at 2:10 p.m. Eastern Time.

How can I access the webcast of Nektar Therapeutics' presentation?

The webcast can be accessed through the Investor Events section on Nektar's website.

Until when will the Nektar Therapeutics presentation be available for replay?

The presentation will be available for replay until July 9, 2021.

What is the focus of Nektar Therapeutics' research and development?

Nektar Therapeutics focuses on investigational medicines in oncology, immunology, and virology.

What stock symbol is associated with Nektar Therapeutics?

Nektar Therapeutics is listed under the stock symbol NKTR.